potential

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment...

The potential use of artificial intelligence for venous thromboembolism prophylaxis and management: clinician and healthcare informatician perspectives

Healthcare informatician—respondent characteristicsOf 101 respondents to the healthcare informatician survey, a majority were greater than 40 years old (54.5%), male (62.0%), and...